Here are five things to know:
1. The market is anticipated to increase at a compound annual growth rate of 6.19 percent between 2016 and 2020.
2. Marketing and promotion initiatives will fuel market growth.
3. An increase in self-medication will also spur market growth.
4. The growing use of counterfeit drugs will hinder market growth.
5. Market vendors include Pfizer, Johnson & Johnson, Sanofi, GlaxoSmithKline and Bayer HealthCare.
More articles on quality & infection control:
Web-based handoff tool and education may reduce medical errors — 7 insights
Antibiotic-resistant infections cost $20B annually & 5 more statistics
4 points on the National Surgical Patient Safety Summit & new surgical safety recommendations
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
